)
Adlai Nortye (ANL) investor relations material
Adlai Nortye Registration filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Management team and governance
Executive officers are employed under fixed-term agreements with provisions for termination for cause or without cause with severance.
Executive officers are bound by confidentiality, invention assignment, non-competition, and non-solicitation clauses during and after employment.
Directors and executive officers are indemnified against certain liabilities and expenses related to their roles.
Board as of April 2026 includes Yang Lu (CEO/Chairman), Xiaofeng (Alex) Ye (CFO), and five other directors, including independent directors.
Offering details and pricing
Registration statement covers up to $600,000,000 in securities to be issued and sold from time to time.
Includes offer and resale by selling securityholders of up to 98,577,627 Class A Ordinary Shares.
Securities may include Class A ordinary shares (including ADSs), debt securities, warrants, subscription rights, and units.
Risk factors and disclosures
Indemnification for directors and officers may be limited by public policy and subject to court adjudication.
Shares are non-assessable, but exceptions exist in cases of fraud or improper purpose.
Company must comply with Cayman Islands sanctions and maintain good standing through annual filings.
- Global oncology innovator offers $600M in securities, advancing RAS and immunotherapy pipeline.ANL
Registration filing23 Apr 2026 - 2025 net loss narrowed, R&D costs fell, and new PIPE and licensing deals boosted liquidity.ANL
Q4 202510 Apr 2026 - Shelf registration enables up to $600M equity offering to fund oncology R&D and growth.ANL
Registration Filing10 Mar 2026 - Net loss improved to $51.9M in 2024; cash $60.9M; AN2025 Phase III topline data due Q2 2025.ANL
Q4 20249 Oct 2025 - AN0025 plus chemoradiotherapy achieved high response and disease control rates with good tolerability.ANL
Investor Presentation3 Jul 2025 - AN4005 demonstrated promising safety and efficacy signals in advanced solid tumors.ANL
Investor Presentation3 Jul 2025 - Tri-specific AN8025 delivers coordinated immune stimulation and strong preclinical anti-tumor efficacy.ANL
Investor Presentation3 Jul 2025 - AN9025 delivers potent, sustained anti-tumor effects in RAS-mutant models and is IND-enabling.ANL
Investor Presentation3 Jul 2025 - Multiple first-in-class oncology assets show strong preclinical and early clinical promise.ANL
Corporate Presentation3 Jul 2025
Next Adlai Nortye earnings date
Next Adlai Nortye earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)